Harding C, Levy M A, Stahl P
Eur J Cell Biol. 1985 Mar;36(2):230-8.
The receptor-mediated endocytosis and intracellular processing of transferrin and mannose receptor ligands were investigated in bone marrow-derived macrophages, fibroblasts and reticulocytes. Mannosylated bovine serum albumin (BSA) conjugated to colloidal gold (Au-man-BSA) or colloidal gold-transferrin (AuTf) were used to trace ligand processing in these cells. These ligands appeared to be processed by mechanisms similar to those observed previously with other mannose receptor and galactose receptor ligand probes. After uptake via coated pits and coated vesicles, Au-man-BSA appeared in small uncoated vesicles and tubular structures and was transferred to large, sometimes multivesicular endosomes (MVEs), which sometimes had arm-like protrusions reminiscent of CURL (compartment of uncoupling of receptor and ligand) [10, 11]. Initially these structures became increasingly multivesicular, but during longer incubations the inclusion vesicles appeared to disintegrate to leave a denser, amorphous lumen. Inclusion vesicle disintegration may result from the introduction of lysosomal enzymes into these structures. These results suggest a model for differential receptor-ligand and ligand-ligand sorting. As suggested [10, 11] membrane constituents may be recycled to the plasma membrane from the arms of CURL. Receptor-bound ligands, such as transferrin, would also recycle. The luminal contents, including dissociated ligands, other soluble proteins and inclusion vesicles (containing some membrane proteins), would target to lysosomes. This would result in the lysosomal degradation of any membrane proteins that were incorporated in the inclusion vesicle membranes.
在源自骨髓的巨噬细胞、成纤维细胞和网织红细胞中,研究了转铁蛋白和甘露糖受体配体的受体介导的内吞作用及细胞内加工过程。将与胶体金偶联的甘露糖基化牛血清白蛋白(BSA)(金-甘露糖-BSA)或胶体金-转铁蛋白(AuTf)用于追踪这些细胞中的配体加工过程。这些配体似乎通过与先前用其他甘露糖受体和半乳糖受体配体探针观察到的机制相似的机制进行加工。通过有被小窝和有被小泡摄取后,金-甘露糖-BSA出现在小的无被小泡和管状结构中,并被转运至大的、有时是多泡的内体(MVE),这些内体有时具有类似CURL(受体与配体解偶联区室)的臂状突起[10, 11]。最初这些结构的多泡性逐渐增加,但在较长时间孵育过程中,内含小泡似乎解体,留下更致密的无定形内腔。内含小泡的解体可能是由于溶酶体酶进入这些结构所致。这些结果提示了一种受体-配体和配体-配体差异分选的模型。如前所述[10, 11],膜成分可能从CURL的臂再循环至质膜。受体结合的配体,如转铁蛋白,也会再循环。腔内成分,包括解离的配体、其他可溶性蛋白质和内含小泡(含有一些膜蛋白),将靶向溶酶体。这将导致内含小泡膜中所含任何膜蛋白的溶酶体降解。